{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T12:05:35Z","timestamp":1785240335097,"version":"3.55.0"},"reference-count":44,"publisher":"MDPI AG","issue":"15","license":[{"start":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T00:00:00Z","timestamp":1785196800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Int. J. Mol. Sci.","IJMS"],"abstract":"<jats:p>Rosmarinic acid (RA), a naturally occurring polyphenolic compound, has attracted increasing attention because of its potential anticancer activity and capacity to modulate oxidative stress-associated signaling pathways. In the present study, the cytotoxic, apoptotic, and antiproliferative effects of RA, alone or in combination with gemcitabine (Gem), were investigated in OVCAR3 ovarian cancer cells and HaCaT keratinocytes using integrated two-dimensional and three-dimensional (3D) experimental models. Cell viability assays demonstrated dose- and time-dependent growth inhibition following RA and Gem treatment, while combination index (CI) analysis revealed synergistic cytotoxic activity in OVCAR3 cells. Flow cytometric analyses showed that combined treatment markedly increased apoptotic cell populations and altered cell cycle progression through enhanced S-phase and G2\/M accumulation. Intracellular reactive oxygen species (ROS) levels were significantly elevated following combination treatment, and N-acetyl-L-cysteine (NAC) pretreatment partially attenuated both ROS accumulation and cytotoxicity, indicating a functional contribution of oxidative stress to the observed antitumor response. RT-qPCR analyses demonstrated increased expression of proapoptotic genes (BAX, CASP3, and CASP9) together with suppression of BCL2, MKI67, and CDK4 expression, while immunocytochemical analyses supported enhanced caspase-3 activation at the protein level. In 3D OVCAR3 tumor spheroids, the RA + Gem combination significantly reduced spheroid viability, disrupted spheroid architecture, and increased dead-cell accumulation compared with single-agent treatments. Collectively, these findings suggest that RA may enhance the anticancer activity of Gem in ovarian cancer cells through mechanisms associated with oxidative stress, apoptosis, and proliferation-related signaling pathways under both monolayer and 3D culture conditions.<\/jats:p>","DOI":"10.3390\/ijms27156741","type":"journal-article","created":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T11:45:26Z","timestamp":1785239126000},"page":"6741","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Rosmarinic Acid Sensitizes Ovarian Cancer Cells to Gemcitabine Through Oxidative Stress-Associated Apoptotic and Antiproliferative Responses"],"prefix":"10.3390","volume":"27","author":[{"given":"Co\u015fkun","family":"Orhaner","sequence":"first","affiliation":[{"name":"Department of Gynecology and Obstetrics, Soranus IVF Center, 16070 Bursa, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7317-5467","authenticated-orcid":false,"given":"Mehmet Cudi","family":"Tuncer","sequence":"additional","affiliation":[{"name":"Department of Anatomy, Faculty of Medicine, Dicle University, 21280 Diyarbak\u0131r, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u0130lhan","family":"\u00d6zdemir","sequence":"additional","affiliation":[{"name":"Department of Histology Embryology, Faculty of Medicine, Kahramanmara\u015f S\u00fct\u00e7\u00fc \u0130mam University, 46000 Kahramanmara\u015f, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,7,28]]},"reference":[{"key":"ref_1","first-page":"17","article-title":"Cancer statistics, 2023","volume":"73","author":"Siegel","year":"2023","journal-title":"CA Cancer J. Clin."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.bpobgyn.2016.08.006","article-title":"Epidemiology of epithelial ovarian cancer","volume":"41","author":"Webb","year":"2017","journal-title":"Best Pract. Res. Clin. Obstet. Gynaecol."},{"key":"ref_3","first-page":"284","article-title":"Ovarian cancer statistics, 2018","volume":"68","author":"Torre","year":"2018","journal-title":"CA Cancer J. Clin."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"2115","DOI":"10.7150\/thno.69424","article-title":"Platinum-Based Drugs for Cancer Therapy and Anti-Tumor Strategies","volume":"12","author":"Zhang","year":"2022","journal-title":"Theranostics"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"7018","DOI":"10.1002\/cam4.2560","article-title":"Ovarian Cancer: Current Status and Strategies for Improving Therapeutic Outcomes","volume":"8","author":"Chandra","year":"2019","journal-title":"Cancer Med."},{"key":"ref_6","first-page":"3","article-title":"Gemcitabine: Metabolism, mechanisms of action, and self-potentiation","volume":"22","author":"Plunkett","year":"1995","journal-title":"Semin. Oncol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1159\/000069315","article-title":"Role of gemcitabine in the treatment of advanced and metastatic breast cancer","volume":"64","author":"Heinemann","year":"2003","journal-title":"Oncology"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1093\/annonc\/mdz062","article-title":"ESMO-ESGO consensus conference recommendations on ovarian cancer: Pathology and molecular biology, early and advanced stages, borderline tumours and recurrent disease","volume":"30","author":"Colombo","year":"2019","journal-title":"Ann. Oncol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"v7","DOI":"10.1093\/annonc\/mdj941","article-title":"Cellular pharmacology of gemcitabine","volume":"17","author":"Mini","year":"2006","journal-title":"Ann. Oncol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1021\/acs.jnatprod.9b01285","article-title":"Natural products as sources of new drugs over the nearly four decades from 01\/1981 to 09\/2019","volume":"83","author":"Newman","year":"2020","journal-title":"J. Nat. Prod."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.semcancer.2016.08.006","article-title":"Bioactive natural products in cancer prevention and treatment: Progress and promise","volume":"40\u201341","author":"Bishayee","year":"2016","journal-title":"Semin. Cancer Biol."},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"Jannati, S., Patel, A., Patnaik, R., and Banerjee, Y. (2025). Oleocanthal as a Multifunctional Anti-Cancer Agent: Mechanistic Insights, Advanced Delivery Strategies, and Synergies for Precision Oncology. Int. J. Mol. Sci., 26.","DOI":"10.3390\/ijms26125521"},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"Af\u015fin, Y., \u00d6zdemir, \u0130., Toprak, V., Tuncer, M.C., and \u00d6zt\u00fcrk, \u015e. (2025). Combined Hesperidin and Gemcitabine Therapy Modulates Apoptosis and Angiogenesis Pathways in ISHIKAWA Human Endometrial Adenocarcinoma Cells. Medicina, 61.","DOI":"10.3390\/medicina61091599"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1055\/s-0035-1568274","article-title":"Rosmarinic acid Pharmaceutical and clinical aspects","volume":"82","author":"Amoah","year":"2016","journal-title":"Planta Med."},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"Nadeem, M., Imran, M., Aslam Gondal, T., Imran, A., Shahbaz, M., Muhammad Amir, R., Wasim Sajid, M., Batool Qaisrani, T., Atif, M., and Hussain, G. (2019). Therapeutic Potential of Rosmarinic Acid: A Comprehensive Review. Appl. Sci., 9.","DOI":"10.3390\/app9153139"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"108086","DOI":"10.5306\/wjco.v16.i7.108086","article-title":"Rosmarinic acid as a targeted modulator of NF-\u03baB signaling in colorectal cancer: A promising adjunct to chemotherapy","volume":"16","author":"Hussain","year":"2025","journal-title":"World J. Clin. Oncol."},{"key":"ref_17","doi-asserted-by":"crossref","unstructured":"Kowalczyk, A., Tuberoso, C.I.G., and Jerkovi\u0107, I. (2024). The Role of Rosmarinic Acid in Cancer Prevention and Therapy: Mechanisms of Antioxidant and Anticancer Activity. Antioxidants, 13.","DOI":"10.3390\/antiox13111313"},{"key":"ref_18","first-page":"5379","article-title":"Characterization of a human ovarian carcinoma cell line (NIH:OVCAR-3) with androgen and estrogen receptors","volume":"43","author":"Hamilton","year":"1983","journal-title":"Cancer Res."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1083\/jcb.106.3.761","article-title":"Normal keratinization in a spontaneously immortalized aneuploid human keratinocyte cell line","volume":"106","author":"Boukamp","year":"1988","journal-title":"J. Cell Biol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"7435621","DOI":"10.1155\/2017\/7435621","article-title":"HaCaT Cells as a Reliable In Vitro Differentiation Model to Dissect the Inflammatory\/Repair Response of Human Keratinocytes","volume":"2017","author":"Colombo","year":"2017","journal-title":"Mediat. Inflamm."},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"Ermogenous, A., Sarigiannidou, E., Psomiadou, M., Panagiotidou, A., Voulgaridou, G.P., Kiousi, D.E., Moyankova, D., Djilianov, D., Galanis, A., and Pappa, A. (2026). Evaluating the Antioxidant, Cytoprotective and Wound-Healing-Associated Effects of Haberlea rhodopensis Ethanolic Extract in Human Skin Keratinocytes. Int. J. Mol. Sci., 27.","DOI":"10.3390\/ijms27104262"},{"key":"ref_22","first-page":"1415","article-title":"Rosmarinic acid inhibits the proliferation of ovarian carcinoma cells by activating the p53\/BAX signaling pathway","volume":"40","author":"Tuncer","year":"2025","journal-title":"Histol. Histopathol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1002\/mnfr.200900414","article-title":"Ursolic acid, a naturally occurring triterpenoid, suppresses migration and invasion of human breast cancer cells by modulating c-Jun N-terminal kinase, Akt and mammalian target of rapamycin signaling","volume":"54","author":"Yeh","year":"2010","journal-title":"Mol. Nutr. Food Res."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1080\/01635581.2010.509835","article-title":"Curcumin, the golden spice from Indian saffron, is a chemosensitizer and radiosensitizer for tumors and chemoprotector and radioprotector for normal organs","volume":"62","author":"Goel","year":"2010","journal-title":"Nutr. Cancer"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"6702","DOI":"10.1038\/sj.onc.1207630","article-title":"Sensitization for anticancer drug-induced apoptosis by the chemopreventive agent resveratrol","volume":"23","author":"Fulda","year":"2004","journal-title":"Oncogene"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1038\/nrm3722","article-title":"Control of apoptosis by the BCL-2 protein family: Implications for physiology and therapy","volume":"15","author":"Czabotar","year":"2014","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1038\/nrm2952","article-title":"Mitochondria and cell death: Outer membrane permeabilization and beyond","volume":"11","author":"Tait","year":"2010","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"ref_28","doi-asserted-by":"crossref","unstructured":"Guan, H., Luo, W., Bao, B., Cao, Y., Cheng, F., Yu, S., Fan, Q., Zhang, L., Wu, Q., and Ung, C.O.L. (2022). A comprehensive review of rosmarinic acid: From phytochemistry to pharmacology and its new insight. Molecules, 27.","DOI":"10.3390\/molecules27103292"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1038\/nrd2803","article-title":"Targeting cancer cells by ROS-mediated mechanisms: A radical therapeutic approach?","volume":"8","author":"Trachootham","year":"2009","journal-title":"Nat. Rev. Drug Discov."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"R453","DOI":"10.1016\/j.cub.2014.03.034","article-title":"ROS function in redox signaling and oxidative stress","volume":"24","author":"Schieber","year":"2014","journal-title":"Curr. Biol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1002\/jcb.22708","article-title":"Anti-invasion effect of rosmarinic acid via the extracellular signal-regulated kinase and oxidation-reduction pathway in Bel-7402 cells","volume":"111","author":"Xu","year":"2010","journal-title":"J. Cell. Biochem."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"3145182","DOI":"10.1155\/2020\/3145182","article-title":"Apatinib, a Novel Tyrosine Kinase Inhibitor, Promotes ROS-Dependent Apoptosis and Autophagy via the Nrf2\/HO-1 Pathway in Ovarian Cancer Cells","volume":"2020","author":"Sun","year":"2020","journal-title":"Oxid. Med. Cell. Longev."},{"key":"ref_33","doi-asserted-by":"crossref","unstructured":"Toprak, V., \u00d6zdemir, \u0130., \u00d6zt\u00fcrk, \u015e., Yanar, O., Kizildemir, Y.Z., and Tuncer, M.C. (2024). Modulation of FOXP3 Gene Expression in OVCAR3 Cells Following Rosmarinic Acid and Doxorubicin Exposure. Pharmaceuticals, 17.","DOI":"10.20944\/preprints202407.2478.v1"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1038\/s41419-024-06939-5","article-title":"Oxidative cell death in cancer: Mechanisms and therapeutic opportunities","volume":"15","author":"An","year":"2024","journal-title":"Cell Death Dis."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"102659","DOI":"10.1016\/j.redox.2023.102659","article-title":"Reactive oxygen species and ovarian diseases: Antioxidant strategies","volume":"62","author":"Liang","year":"2023","journal-title":"Redox Biol."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"100178","DOI":"10.1016\/j.adcanc.2026.100178","article-title":"Integrative transcriptomic analysis of WNT\/TGF\u03b2-driven EMT pathways and drug-gene interaction networks in epithelial ovarian cancer","volume":"16","author":"Heidarzadehpilehrood","year":"2026","journal-title":"Adv. Cancer Biol. Metastasis"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1200\/JCO.2011.36.1196","article-title":"PI3K\/AKT\/mTOR inhibitors in patients with breast and gynecologic malignancies harboring PIK3CA mutations","volume":"30","author":"Janku","year":"2012","journal-title":"J. Clin. Oncol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"2278","DOI":"10.1200\/JCO.2008.20.0766","article-title":"Targeting the mTOR signaling network for cancer therapy","volume":"27","year":"2009","journal-title":"J. Clin. Oncol."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/j.ccr.2014.01.021","article-title":"Mutant p53 in cancer: New functions and therapeutic opportunities","volume":"25","author":"Muller","year":"2014","journal-title":"Cancer Cell"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"W90","DOI":"10.1093\/nar\/gkw377","article-title":"Enrichr: A comprehensive gene set enrichment analysis web server 2016 update","volume":"44","author":"Kuleshov","year":"2016","journal-title":"Nucleic Acids Res."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1101\/gad.13.12.1501","article-title":"CDK inhibitors: Positive and negative regulators of G1-phase progression","volume":"13","author":"Sherr","year":"1999","journal-title":"Genes Dev."},{"key":"ref_42","doi-asserted-by":"crossref","unstructured":"Zigov\u00e1, M., Mi\u0161kufov\u00e1, V., Budovsk\u00e1, M., Michalkov\u00e1, R., and Moj\u017ei\u0161, J. (2024). Exploring the Antiproliferative and Modulatory Effects of 1-Methoxyisobrassinin on Ovarian Cancer Cells: Insights into Cell Cycle Regulation, Apoptosis, Autophagy, and Its Interactions with NAC. Molecules, 29.","DOI":"10.3390\/molecules29081773"},{"key":"ref_43","doi-asserted-by":"crossref","unstructured":"Maybee, D.V., Psaras, A.M., Brooks, T.A., and Ali, M.A.M. (2022). RYBP Sensitizes Cancer Cells to PARP Inhibitors by Regulating ATM Activity. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms231911764"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"2741","DOI":"10.32604\/or.2025.067126","article-title":"Cancer 3D Models: Essential Tools for Understanding and Overcoming Drug Resistance","volume":"33","author":"Dragoj","year":"2025","journal-title":"Oncol. Res."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/27\/15\/6741\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T11:48:45Z","timestamp":1785239325000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/27\/15\/6741"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,28]]},"references-count":44,"journal-issue":{"issue":"15","published-online":{"date-parts":[[2026,8]]}},"alternative-id":["ijms27156741"],"URL":"https:\/\/doi.org\/10.3390\/ijms27156741","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,28]]}}}